Creative Medical Technolo...

NASDAQ: CELZ · Real-Time Price · USD
3.07
0.00 (0.00%)
At close: Aug 15, 2025, 3:50 PM

Creative Medical Technology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
11K 9K 88.6K 87.75K
Cost of Revenue
4.4K 3.6K 28.49K 47.95K
Gross Profit
6.6K 5.4K 60.11K 39.8K
Operating Income
-5.74M -5.62M -10.24M -3.13M
Interest Income
250.38K 333.56K 100.33K n/a
Pretax Income
-5.49M -5.29M -10.14M 19.21M
Net Income
-5.49M -5.29M -10.14M 19.21M
Selling & General & Admin
3.24M 3.56M 3.94M 2.96M
Research & Development
2.4M 1.97M 6.27M 109.18K
Other Expenses
110.45K 94.58K 92.08K 92.08K
Operating Expenses
5.75M 5.63M 10.3M 3.17M
Interest Expense
n/a n/a n/a 4.28M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
5.75M 5.63M 10.33M 3.21M
Income Tax Expense
n/a n/a -100.33K 4.28M
Shares Outstanding (Basic)
1.48M 1.41M 1.09M 260.5K
Shares Outstanding (Diluted)
1.48M 1.41M 1.09M 324.86K
EPS (Basic)
-3.71 -3.76 -9.28 73.75
EPS (Diluted)
-3.71 -3.76 -9.28 56.10
EBITDA
-5.63M -5.53M -10.15M 23.58M
EBIT
-5.74M -5.62M -10.24M 23.49M
Depreciation & Amortization
110.45K 94.58K 92.08K 92.08K